Sweden Pharmaceuticals & Healthcare Q4 2019
Sweden’s pharmaceutical market growth will remain above the Western European average over the forecast period,creating renewed opportunities for drugmakers. The relatively small market size by regional standards and aggressive drug pricingpolicies will continue to weigh on market potential. The government will remain committed towards supporting healthcareinnovations and personalised medical treatment development, while pharmaceutical exports will continue to grow.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook